A combination of xanomeline and trospium chloride (brand name Cobenfy) is an FDA-approved medication for the treatment of schizophrenia.
- TRADE NAMES: Regurin; Sanctura (Allergan)
- INDICATIONS: Overactive bladder
- CLASS: Anticholinergic, Antispasmodic, Muscarinic antagonist
- HALF-LIFE: 20 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Anticholinergics, Antihistamines, Botulinum Toxin (A & B), Cannabinoids, Clozapine, Disopyramide, Domperidone, Haloperidol, Ketoconazole, Levodopa, MAOIs, Memantine, Metformin, Metoclopramide, Morphine, Nefopam, Pancuronium, Parasypathomimetics, Phenothiazines, Pramlintide, Procainamide, Secretin, Tenofovir Disoproxil, Tricyclic antidepressants, Vancomycin
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 10/14/2025
